EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Select your location
Local sites
How life sciences companies can navigate President Trump’s trade policies
In this webcast, panelists discuss the impacts of President Trump’s trade agenda on the supply chains of life sciences companies.
In this webcast, panelists highlight key considerations for life sciences businesses as they model impacts of President Trump’s trade agenda and retaliatory tariffs on their supply chains and across the enterprise. We will cover the following topics:
- Current US trade policy landscape affecting life sciences companies
- Wider geopolitical aspects impacting trade operations and supply chain strategies
- Supply chain considerations in light of global trade dynamics
- Tax and trade considerations tailored for the life science sector
- Immediate steps to take for effective adaptation and assessment
At the end of the webcast, viewers should be able to:
- Recognize the potential implications of Trump’s trade policy on their operations
- Understand the importance of assessing alternative sourcing or manufacturing, customs valuation and supply chain resilience
- Develop a proactive approach to anticipated changes in both US and foreign trade policy
Panelists:
- Matthew Burton, Partner, Supply Chain & Operations, Ernst & Young LLP
- Famke Krumbmüller, Associate Partner, Geostrategic Business Group, Ernst & Young Advisory
- Frank-Peter Ziegler, Partner, Indirect tax, EY Tax GmbH Steuerberatungsgesellschaft